The Society for Medicines Research (SMR) will host a one-day meeting on Target Identification and Validation in Drug Discovery on Friday, 24 October 2025, at DISC (AstraZeneca), Cambridge.
This event will bring together leading experts from both academia and industry to explore the latest advances and emerging technologies shaping the field of target discovery and validation. Attendees will gain insights into breakthrough research, innovative methodologies, and successful case studies driving the next generation of therapeutic development.
The meeting offers a valuable opportunity for scientists and professionals to connect, exchange ideas, and stay informed about the evolving landscape of drug discovery and translational medicine.
You can find more posts featuring AstraZeneca on OncoDaily.